Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.180
+0.010 (5.88%)
At close: Dec 20, 2024, 4:00 PM
0.183
+0.003 (1.67%)
After-hours: Dec 20, 2024, 7:31 PM EST
Lyra Therapeutics Stock Forecast
LYRA's stock price has decreased by -96.39% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Lyra Therapeutics stock have an average target of 4.50, with a low estimate of 0.50 and a high estimate of 11. The average target predicts an increase of 2,400.00% from the current stock price of 0.18.
Analyst Consensus: Buy
* Price targets were last updated on Aug 15, 2024.
Analyst Ratings
The average analyst rating for LYRA stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | +1,011.11% | Aug 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $2 | Strong Buy → Hold | Downgrades | $2 | +1,011.11% | May 7, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $10 → $0.5 | Strong Buy → Hold | Downgrades | $10 → $0.5 | +177.78% | May 7, 2024 |
Financial Forecast
Revenue This Year
1.55M
from 1.56M
Decreased by -0.58%
Revenue Next Year
797.44K
from 1.55M
Decreased by -48.52%
EPS This Year
-1.37
from -1.26
EPS Next Year
-0.65
from -1.37
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.8M | 1.7M | 19.8M | |||
| Avg | 1.5M | 797,436 | 8.1M | |||
| Low | 1.3M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 14.6% | 7.7% | 2,388.6% | |||
| Avg | -0.6% | -48.5% | 918.0% | |||
| Low | -18.2% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.22 | -0.38 | -0.25 | |||
| Avg | -1.37 | -0.65 | -0.74 | |||
| Low | -1.39 | -1.01 | -1.07 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.